RI
TGTX icon

Redwood Investments’s TG Therapeutics TGTX Stock Holding History

Redwood Investments’s Portfolio TGTX Stock Details TGTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		$3.68M Sell
93,242
-1,312
-1% -$44.1K 1.38% 24
2024
Q4 		$2.85M Buy
94,554
+886
+0.9% +$25.4K 0.76% 36
2024
Q3 		$2.19M Buy
+93,668
New +$2.05M 0.65% 47

Other funds holding TGTX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $94.8B AUM 24.11% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Redwood Investments's TGTX Position: Q1 2025 in Review

Redwood Investments reduced its TG Therapeutics (TGTX) stake by 1.4% in Q1 2025, selling an estimated $44.1K and leaving 93,242 shares worth $3.68M. The position accounts for 1.38% of the portfolio, ranked #24.

Redwood Investments first reported a position in TGTX in Q3 2024 and has held it in 3 quarters since. 376 funds tracked by Wall St. Rank hold TGTX as of Q1 2025.

  • Redwood Investments held 93,242 shares of TG Therapeutics worth $3.68M as of Q1 2025.
  • Redwood Investments sold 1,312 TG Therapeutics shares in Q1 2025, an estimated $44.1K.
  • TG Therapeutics made up 1.38% of Redwood Investments's portfolio in Q1 2025, its #24 holding.
  • Redwood Investments first reported a position in TG Therapeutics in Q3 2024 and has held it in 3 quarters since.
  • 376 funds tracked by Wall St. Rank held TG Therapeutics as of Q1 2025.

Based on Redwood Investments's 13F filing for Q1 2025, filed 16 May 2025.